{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:44:52Z","timestamp":1782895492493,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12010-023-04845-8","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T10:02:03Z","timestamp":1704362523000},"page":"5974-5993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pan-Cancer Analysis of P3H1 and Experimental Validation in Renal Clear Cell Carcinoma"],"prefix":"10.1007","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4194-5399","authenticated-orcid":false,"given":"Yongjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"4845_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., et al. (2021). Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"4845_CR2","doi-asserted-by":"publisher","unstructured":"Yang, M., Oh, I. Y., Mahanty, A., Jin, W. L., & Yoo, J. S. (2020). Immunotherapy for glioblastoma: current state, challenges, and future perspectives, Cancers (Basel), 12. https:\/\/doi.org\/10.3390\/cancers12092334","DOI":"10.3390\/cancers12092334"},{"key":"4845_CR3","doi-asserted-by":"publisher","first-page":"113674","DOI":"10.1016\/j.biopha.2022.113674","volume":"155","author":"D Bisht","year":"2022","unstructured":"Bisht, D., Arora, A., & Sachan, M. (2022). Role of dna de-methylation intermediate \u201c5-hydroxymethylcytosine\u201d in ovarian cancer management: A comprehensive review. Biomedicine & Pharmacotherapy, 155, 113674. https:\/\/doi.org\/10.1016\/j.biopha.2022.113674","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"4845_CR4","doi-asserted-by":"publisher","unstructured":"Liu, X., Chen, L., & Wang, T. (2022). Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the mir-200a-3p-gls axis, J Chemother, 1\u201310. https:\/\/doi.org\/10.1080\/1120009X.2022.2111490.","DOI":"10.1080\/1120009X.2022.2111490"},{"key":"4845_CR5","doi-asserted-by":"publisher","first-page":"17253","DOI":"10.1074\/jbc.M110.102228","volume":"285","author":"JA Vranka","year":"2010","unstructured":"Vranka, J. A., Pokidysheva, E., Hayashi, L., Zientek, K., Mizuno, K., et al. (2010). Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones. Journal of Biological Chemistry, 285, 17253\u201317262. https:\/\/doi.org\/10.1074\/jbc.M110.102228","journal-title":"Journal of Biological Chemistry"},{"key":"4845_CR6","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1007\/s00018-019-03102-8","volume":"76","author":"J Wu","year":"2019","unstructured":"Wu, J., Zhang, W., Xia, L., Feng, L., Shu, Z., et al. (2019). Characterization of ppib interaction in the p3h1 ternary complex and implications for its pathological mutations. Cellular and Molecular Life Sciences, 76, 3899\u20133914. https:\/\/doi.org\/10.1007\/s00018-019-03102-8","journal-title":"Cellular and Molecular Life Sciences"},{"key":"4845_CR7","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1074\/jbc.M116.762245","volume":"292","author":"DM Hudson","year":"2017","unstructured":"Hudson, D. M., Weis, M., Rai, J., Joeng, K. S., Dimori, M., et al. (2017). P3h3-null and sc65-null mice phenocopy the collagen lysine under-hydroxylation and cross-linking abnormality of ehlers-danlos syndrome type via. Journal of Biological Chemistry, 292, 3877\u20133887. https:\/\/doi.org\/10.1074\/jbc.M116.762245","journal-title":"Journal of Biological Chemistry"},{"key":"4845_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.matbio.2020.02.003","volume":"90","author":"WA Cabral","year":"2020","unstructured":"Cabral, W. A., Fratzl-Zelman, N., Weis, M., Perosky, J. E., Alimasa, A., et al. (2020). Substitution of murine type i collagen a1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia. Matrix Biology, 90, 20\u201339. https:\/\/doi.org\/10.1016\/j.matbio.2020.02.003","journal-title":"Matrix Biology"},{"key":"4845_CR9","doi-asserted-by":"publisher","first-page":"5068523","DOI":"10.1155\/2022\/5068523","volume":"2022","author":"W Tan","year":"2022","unstructured":"Tan, W., Ji, Y., Qian, Y., Lin, Y., Ye, R., et al. (2022). Mutational screening of skeletal genes in 14 chinese children with osteogenesis imperfecta using targeted sequencing. Journal of Immunology Research, 2022, 5068523. https:\/\/doi.org\/10.1155\/2022\/5068523","journal-title":"Journal of Immunology Research"},{"key":"4845_CR10","doi-asserted-by":"publisher","unstructured":"Zhytnik, L., Duy, B. H., Eekhoff, M., Wisse, L., & Pals, G., et al. (2022) Phenotypic variation in vietnamese osteogenesis imperfecta patients sharing a recessive p3h1 pathogenic variant, Genes (Basel), 13. https:\/\/doi.org\/10.3390\/genes13030407","DOI":"10.3390\/genes13030407"},{"key":"4845_CR11","doi-asserted-by":"publisher","unstructured":"Nadyrshina, D., Zaripova, A., Tyurin, A., Minniakhmetov, I., Zakharova, E., & Khusainova, R. (2022). Osteogenesis imperfecta: search for mutations in patients from the republic of bashkortostan (russia), Genes (Basel), 13. https:\/\/doi.org\/10.3390\/genes13010124","DOI":"10.3390\/genes13010124"},{"key":"4845_CR12","doi-asserted-by":"publisher","first-page":"116293","DOI":"10.1016\/j.bone.2021.116293","volume":"155","author":"B Tuysuz","year":"2022","unstructured":"Tuysuz, B., Elkanova, L., Uludag, A. D., Gulec, C., Toksoy, G., et al. (2022). Osteogenesis imperfecta in 140 turkish families: Molecular spectrum and comparison of long-term clinical outcome of those with col1a1\/a2 and biallelic variants. Bone, 155, 116293. https:\/\/doi.org\/10.1016\/j.bone.2021.116293","journal-title":"Bone"},{"key":"4845_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12881-018-0521-0","volume":"19","author":"P Scollo","year":"2018","unstructured":"Scollo, P., Snead, M. P., Richards, A. J., Pollitt, R., & Devile, C. (2018). Bilateral giant retinal tears in osteogenesis imperfecta. BMC Medical Genetics, 19, 8. https:\/\/doi.org\/10.1186\/s12881-018-0521-0","journal-title":"BMC Medical Genetics"},{"key":"4845_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.matbio.2012.11.006","volume":"32","author":"E Pokidysheva","year":"2013","unstructured":"Pokidysheva, E., Tufa, S., Bresee, C., Brigande, J. V., & Bachinger, H. P. (2013). Prolyl 3-hydroxylase-1 null mice exhibit hearing impairment and abnormal morphology of the middle ear bone joints. Matrix Biology, 32, 39\u201344. https:\/\/doi.org\/10.1016\/j.matbio.2012.11.006","journal-title":"Matrix Biology"},{"key":"4845_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41065-019-0100-1","volume":"156","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Liu, G., Hossain, A., Danilova, I. G., Bolkov, M. A., et al. (2019). A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival. Hereditas, 156, 24. https:\/\/doi.org\/10.1186\/s41065-019-0100-1","journal-title":"Hereditas"},{"key":"4845_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.yexcr.2017.12.020","volume":"363","author":"Y Li","year":"2018","unstructured":"Li, Y., Chen, Y., Ma, Y., Nenkov, M., Haase, D., & Petersen, I. (2018). Collagen prolyl hydroxylase 3 has a tumor suppressive activity in human lung cancer. Experimental Cell Research, 363, 121\u2013128. https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.020","journal-title":"Experimental Cell Research"},{"key":"4845_CR17","doi-asserted-by":"publisher","first-page":"1289445","DOI":"10.1155\/2022\/1289445","volume":"2022","author":"W Xue","year":"2022","unstructured":"Xue, W., Sun, C., Yuan, H., Yang, X., Zhang, Q., et al. (2022). Establishment and analysis of an individualized emt-related gene signature for the prognosis of breast cancer in female patients. Disease Markers, 2022, 1289445. https:\/\/doi.org\/10.1155\/2022\/1289445","journal-title":"Disease Markers"},{"key":"4845_CR18","doi-asserted-by":"publisher","first-page":"901671","DOI":"10.3389\/fimmu.2022.901671","volume":"13","author":"P Zhou","year":"2022","unstructured":"Zhou, P., Liu, Z., Hu, H., Lu, Y., Xiao, J., et al. (2022). Comprehensive analysis of senescence characteristics defines a novel prognostic signature to guide personalized treatment for clear cell renal cell carcinoma. Frontiers in Immunology, 13, 901671. https:\/\/doi.org\/10.3389\/fimmu.2022.901671","journal-title":"Frontiers in Immunology"},{"key":"4845_CR19","doi-asserted-by":"publisher","unstructured":"Consortium G. (2013). The genotype-tissue expression (gtex) project. Nature Genetics, 45, 580-585.https:\/\/doi.org\/10.1038\/ng.2653","DOI":"10.1038\/ng.2653"},{"key":"4845_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","volume":"180","author":"DP Nusinow","year":"2020","unstructured":"Nusinow, D. P., Szpyt, J., Ghandi, M., Rose, C. M., Mcdonald, E. R., et al. (2020). Quantitative proteomics of the cancer cell line encyclopedia. Cell, 180, 387\u2013402. https:\/\/doi.org\/10.1016\/j.cell.2019.12.023","journal-title":"Cell"},{"key":"4845_CR21","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak, K., Czerwinska, P., & Wiznerowicz, M. (2015). The cancer genome atlas (tcga): An immeasurable source of knowledge. Contemp Oncol (Pozn), 19, A68\u2013A77. https:\/\/doi.org\/10.5114\/wo.2014.47136","journal-title":"Contemp Oncol (Pozn)"},{"key":"4845_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J., Craft, B., Hastie, M., Repecka, K., Mcdade, F., et al. (2020). Visualizing and interpreting cancer genomics data via the xena platform. Nature Biotechnology, 38, 675\u2013678. https:\/\/doi.org\/10.1038\/s41587-020-0546-8","journal-title":"Nature Biotechnology"},{"key":"4845_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., et al. (2012). The cbio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2, 401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discovery"},{"key":"4845_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","volume":"7","author":"D Zeng","year":"2019","unstructured":"Zeng, D., Li, M., Zhou, R., Zhang, J., Sun, H., et al. (2019). Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunology Research, 7, 737\u2013750. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0436","journal-title":"Cancer Immunology Research"},{"key":"4845_CR25","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., et al. (2020). Timer2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Research, 48, W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Research"},{"key":"4845_CR26","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., et al. (2013). Genomics of drug sensitivity in cancer (gdsc): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Research, 41, D955\u2013D961. https:\/\/doi.org\/10.1093\/nar\/gks1111","journal-title":"Nucleic Acids Research"},{"key":"4845_CR27","doi-asserted-by":"publisher","first-page":"986990","DOI":"10.3389\/fonc.2022.986990","volume":"12","author":"W Lv","year":"2022","unstructured":"Lv, W., Shi, L., Pan, J., & Wang, S. (2022). Comprehensive prognostic and immunological analysis of cct2 in pan-cancer. Frontiers in Oncology, 12, 986990. https:\/\/doi.org\/10.3389\/fonc.2022.986990","journal-title":"Frontiers in Oncology"},{"key":"4845_CR28","doi-asserted-by":"publisher","first-page":"5551036","DOI":"10.1155\/2021\/5551036","volume":"2021","author":"F Chen","year":"2021","unstructured":"Chen, F., Fan, Y., Cao, P., Liu, B., Hou, J., et al. (2021). Pan-cancer analysis of the prognostic and immunological role of hsf1: A potential target for survival and immunotherapy. Oxidative Medicine and Cellular Longevity, 2021, 5551036. https:\/\/doi.org\/10.1155\/2021\/5551036","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"4845_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/03008207.2021.1932853","volume":"63","author":"IM Erbas","year":"2022","unstructured":"Erbas, I. M., Ilgun, G. D., Manav, K. Z., Koc, A., Unuvar, T., et al. (2022). Clinical, genetic characteristics and treatment outcomes of children and adolescents with osteogenesis imperfecta: A two-center experience. Connective Tissue Research, 63, 349\u2013358. https:\/\/doi.org\/10.1080\/03008207.2021.1932853","journal-title":"Connective Tissue Research"},{"key":"4845_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ajmg.a.61934","volume":"185","author":"LT de Souza","year":"2021","unstructured":"de Souza, L. T., Nunes, R. R., de Azevedo, M. O., & Maria, F. T. (2021). A new case of osteogenesis imperfecta type viii and retinal detachment. American Journal of Medical Genetics. Part A, 185, 238\u2013241. https:\/\/doi.org\/10.1002\/ajmg.a.61934","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"4845_CR31","doi-asserted-by":"publisher","first-page":"850015","DOI":"10.3389\/fimmu.2022.850015","volume":"13","author":"C Tang","year":"2022","unstructured":"Tang, C., Fang, M., Tan, G., Zhang, S., Yang, B., et al. (2022). Discovery of novel circulating immune complexes in lupus nephritis using immunoproteomics. Frontiers in Immunology, 13, 850015. https:\/\/doi.org\/10.3389\/fimmu.2022.850015","journal-title":"Frontiers in Immunology"},{"key":"4845_CR32","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1038\/s41598-019-51999-9","volume":"9","author":"DR Gawel","year":"2019","unstructured":"Gawel, D. R., Lee, E. J., Li, X., Lilja, S., Matussek, A., et al. (2019). An algorithm-based meta-analysis of genome- and proteome-wide data identifies a combination of potential plasma biomarkers for colorectal cancer. Science and Reports, 9, 15575. https:\/\/doi.org\/10.1038\/s41598-019-51999-9","journal-title":"Science and Reports"},{"key":"4845_CR33","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/21655979.2020.1822715","volume":"11","author":"C Xiong","year":"2020","unstructured":"Xiong, C., Wang, G., & Bai, D. (2020). A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes. Bioengineered, 11, 1034\u20131046. https:\/\/doi.org\/10.1080\/21655979.2020.1822715","journal-title":"Bioengineered"},{"key":"4845_CR34","doi-asserted-by":"publisher","first-page":"5538756","DOI":"10.1155\/2021\/5538756","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Li, C. Y., Pan, M., Li, J. Y., Ge, W., et al. (2021). Exploration of the key proteins of high-grade intraepithelial neoplasia to adenocarcinoma sequence using in-depth quantitative proteomics analysis. J Oncol, 2021, 5538756. https:\/\/doi.org\/10.1155\/2021\/5538756","journal-title":"J Oncol"},{"key":"4845_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02366-y","author":"W He","year":"2022","unstructured":"He, W., Lin, S., Guo, Y., Wu, Y., Zhang, L. L., et al. (2022). Targeted demethylation at znf154 promotor upregulates znf154 expression and inhibits the proliferation and migration of esophageal squamous carcinoma cells. Oncogene. https:\/\/doi.org\/10.1038\/s41388-022-02366-y","journal-title":"Oncogene"},{"key":"4845_CR36","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/151911","author":"EG Avram","year":"2022","unstructured":"Avram, E. G., Moatar, I. A., Miok, V., Baderca, F., Samoila, C., et al. (2022). Gene network analysis of the transcriptome impact of methylated micrornas on oral squamous cell carcinoma. Advances in Clinical and Experimental Medicine. https:\/\/doi.org\/10.17219\/acem\/151911","journal-title":"Advances in Clinical and Experimental Medicine"},{"key":"4845_CR37","doi-asserted-by":"publisher","unstructured":"Xu, Q., Lan, X., Lin, H., Xi, Q., & Wang, M., et al. (2022). Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, e1842. https:\/\/doi.org\/10.1002\/wnan.1842.","DOI":"10.1002\/wnan.1842"},{"key":"4845_CR38","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1002\/cam4.2983","volume":"9","author":"J Luo","year":"2020","unstructured":"Luo, J., Xie, Y., Zheng, Y., Wang, C., Qi, F., et al. (2020). Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the estimate algorithm. Cancer Medicine, 9, 4310\u20134323. https:\/\/doi.org\/10.1002\/cam4.2983","journal-title":"Cancer Medicine"},{"key":"4845_CR39","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K., Shahmoradgoli, M., Martinez, E., Vegesna, R., Kim, H., et al. (2013). Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Communications, 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612","journal-title":"Nature Communications"},{"key":"4845_CR40","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2217\/imt-2016-0045","volume":"8","author":"L Signorini","year":"2016","unstructured":"Signorini, L., Delbue, S., Ferrante, P., & Bregni, M. (2016). Review on the immunotherapy strategies against metastatic colorectal carcinoma. Immunotherapy-Uk, 8, 1245\u20131261. https:\/\/doi.org\/10.2217\/imt-2016-0045","journal-title":"Immunotherapy-Uk"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04845-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04845-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04845-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T14:17:40Z","timestamp":1732803460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04845-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4845"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04845-8","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"19 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experiments were conducted in accordance with the ethical guidelines of Shaoyang University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that there are no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}